BRIEF—European Clinical Research Alliance on Infectious Diseases kicks off

Kicking off today (January 17) was the high-level meeting in Brussels, PREPARE and COMBACTE, which will commence the development of the business plan for ECRAID, the European Clinical Research Alliance on Infectious Diseases.

ECRAID envisages a European-wide sustainable clinical research organization for infectious diseases and antimicrobial resistance that stems from both PREPARE and COMBACTE.

ECRAID's vision is to establish a coordinated and permanent European clinical research infrastructure for clinical research on infectious diseases.

Due to its network, which is built on the foundations laid by COMBACTE (>950 clinical care sites) and PREPARE (primary care sites), the ECRAID will be able to conduct clinical research faster and easier.

Moreover, the ECRAID will have rapid access to and knowledge of well-developed clinical and laboratory sites.

Trials will be conducted continuously, allowing them to expand their experience and knowledge.

ECRAID aims to protect public health by generating rigorous evidence to improve diagnosis, prevention, and treatment.

The mission is to cultivate world-class research to protect citizens of Europe against antimicrobial resistance and infectious diseases over the long-term.